Contact Us

For more information about Qutenza, please use the contact information below.






Averitas Pharma, Inc..
360 Mt. Kemble Ave. 3rd FL, Ste 3,
Morristown, NJ 07960




Adverse Event Reporting

Physicians, other health care providers and patients are encouraged to voluntarily report adverse events involving drugs or medical devices. To make a report you can:


Qutenza® is indicated for the management of neuropathic pain associated with postherpetic neuralgia.



Treatment with Qutenza® must be performed only by a healthcare provider. You should never apply or remove Qutenza® yourself.


Warnings and Precautions:

Side Effects:

In clinical studies, the most common drug-related side effects of Qutenza®, which occurred in 5% or more of patients, included redness, pain, itching, or small bumps where Qutenza® was applied, and nausea. You should tell your doctor if any side effects bother you or do not go away. These are not all the side effects of Qutenza®. For more information, ask your healthcare provider or pharmacist.


Please click here for full Prescribing Information.


Carton with one patch + cleansing gel: NDC number #10144-0928-01

Carton with two patches + cleansing gel: NDC number #10144-0929-01

Qutenza® is a registered trademark of Averitas Pharma, Inc.

© 2018 Averitas Pharma, Inc. All rights reserved.

This site is intended for residents of the United States only.